Related Experiment Video
Updated: Jun 2, 2026
16:13
Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
Published on: June 13, 2011
Migraine and depression: common pathogenetic and therapeutic ground?
F Moschiano1, D D'Amico, I Canavero
1National Institute of Neurology, IRCCS C. Mondino Foundation, Via Mondino 2, 27100 Pavia, Italy. franca.moschiano@mondino.it
Summary
Migraine and depression frequently co-occur, potentially due to shared mechanisms. This review explores treatment strategies for patients experiencing both migraine and depression.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Medicine
Background:
- Migraine and depression are frequently comorbid, supported by epidemiological data.
- Shared neurobiological mechanisms are suggested but not fully understood.
- Limited research exists on effective therapeutic strategies for this dual comorbidity.
Purpose of the Study:
- To review current literature on migraine and depression comorbidity.
- To explore potential shared neurobiological underpinnings.
- To discuss therapeutic options for managing patients with both conditions.
Main Methods:
- Literature review of epidemiological, neurobiological, and clinical studies.
- Synthesis of findings on comorbidity and shared mechanisms.
- Discussion of treatment implications.
Main Results:
- Epidemiological evidence confirms a significant association between migraine and depression.
- Several plausible shared neurobiological pathways are identified.
- Current literature highlights a gap in studies specifically addressing combined therapeutic approaches.
Conclusions:
- The comorbidity of migraine and depression is well-established, likely involving common neurobiological factors.
- Further research is needed to develop and validate targeted treatment strategies for comorbid migraine and depression.
- Integrated treatment approaches may offer improved outcomes for affected individuals.
Related Concept Videos
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...